Renal Impairment: No dosage modification is recommended in patients with mild renal impairment (CLcr 51-80 mL/min estimated by Cockcroft-Gault). In patients with moderate renal impairment (CLcr 31-50 ...
Renal Impairment: No dosage modification is recommended in patients with mild renal impairment (CLcr 51-80 mL/min estimated by Cockcroft-Gault). In patients with moderate renal impairment (CLcr 31-50 ...
Renal Impairment: No dosage modification is recommended in patients with mild renal impairment (CLcr 51-80 mL/min estimated by Cockcroft-Gault). In patients with moderate renal impairment (CLcr 31 ...
Mean ± S.D. 0.8 ± 0.3 0.9 ± 0.2 0.8 ± 0.3 Median (range) 0.7 (0.5-1.8) 0.8 (0.6-1.3) 0.8 (0.5-1.8) Total body weight (kg) Mean ± S.D. 132.7 ± 35.0 158.7 ± 47.6 142.3 ± 41.7 Median (range ...
Renal Impairment: No dosage modification of INQOVI is recommended for patients with mild or moderate renal impairment (creatinine clearance [CLcr] of 30 to 89 mL/min based on Cockcroft-Gault).
Renal Impairment: No dosage modification of INQOVI is recommended for patients with mild or moderate renal impairment (creatinine clearance [CLcr] of 30 to 89 mL/min based on Cockcroft-Gault). Due to ...
Halifax Paralympian Hannah Cockroft OBE returned to her old school this week in an inspiring visit. The Team GB champion visited students and shared her road to glory and story of how she became the ...
Hannah Cockcroft took to the world stage in September, winning gold in the 100m event at the Paris Paralympics, taking her ninth win. She's an inspiration in every sense of the word, a world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback